Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from American Tower

Should You Buy the Dip in Real Estate Stocks Now?

After reasonable pullbacks in their stock prices, these three real estate stocks could be strong buys in today's market, backed by fundamentals.

MarketBeat

Is American Tower Stock Underperforming the Dow?

American Tower has underperformed the Dow recently, but analysts are moderately optimistic about the stock’s prospects.

Barchart

Do Wall Street Analysts Like American Tower Stock?

Despite underperforming the broader market over the past year, analysts remain moderately bullish on American Tower’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

What to Expect From American Tower's Q3 2024 Earnings Report

American Tower is poised to release its third-quarter results later this month, and analysts expect a single-digit earnings decline.

Barchart

Is American Tower Stock Outperforming the Nasdaq?

Despite American Tower’s underperformance compared to the broader Nasdaq Composite over the past year, Wall Street analysts remain optimistic about the stock’s prospects.

Barchart

American Tower Stock Outlook: Is Wall Street Bullish or Bearish?

Despite American Tower underperforming the broader market over the past year, analysts remain bullish about the stock’s prospects.

Barchart

3 Best REIT Dividend Stocks to Buy Now

These three REITs offer attractive dividend yields.

Barchart

Read news from The Economist, FT, and more,
with one subscription

5 'Pick and Shovel' AI Growth Stocks to Scoop Up Now

With AI demand rising and data centers set for explosive growth, these AI infrastructure providers emerge as prime investment opportunities now.

Barchart

3 'Strong Buy' REITs to Buy for Passive Income

Discover three 'Strong Buy'-rated REITs that offer attractive dividend yields and significant upside potential for passive income investors.

Barchart

Is American Tower Stock Underperforming the S&P 500?

Despite American Tower's lackluster performance compared to the broader S&P 500 Index, Wall Street analysts remain bullish on the stock’s prospects.

Barchart

Europe’s telecom infrastructure: A vision for connectivity and sustainability

THE ARTICLES ON THESE PAGES ARE PRODUCED BY BUSINESS REPORTER, WHICH TAKES SOLE RESPONSIBILITY FOR THE CONTENTS

The Independent UK

3 'Strong Buy' Stocks to Invest in for the Next Wave of AI

Early AI leaders like Nvidia may be among the most sought-after stocks in the market now, but with the next wave of adoption on the horizon, here are three more top tech stocks that analysts recommend.

Barchart

Stock Index Futures Tick Higher as Investors Brace for U.S. Economic Data

March S&P 500 E-Mini futures (ESH24) are up +0.07%, and March Nasdaq 100 E-Mini futures (NQH24) are up +0.15% this morning as investors geared up for a fresh batch of U.S. economic data.

Barchart

Are These 2 Beaten-Down REITs Worth Buying for Their High Dividend Yields?

These tower REITs look to offer compelling value after their catastrophic implosions, though the current macroeconomic environment poses plenty of challenges.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Stay Connected With These 2 Cell Tower REITs Offering Steady Dividends

As wireless carriers such as Verizon Communications (NYSE: VZ) and T-Mobile US (NASDAQ: TMUS) switch their wireless carriers from 4G to 5G, the demand for cell towers and fiber optic lines will continue to rise.

Benzinga

Check Out What Whales Are Doing With AMT

Someone with a lot of money to spend has taken a bearish stance on American Tower (NYSE:AMT). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Expert Ratings for American Tower

Within the last quarter, American Tower (NYSE:AMT) has observed the following analyst ratings:

Benzinga

Here's How Much You Would Have Made Owning American Tower Stock In The Last 10 Years

American Tower (NYSE:AMT) has outperformed the market over the past 10 years by 2.78% on an annualized basis producing an average annual return of 14.08%. Currently, American Tower has a market capitalization of $121.13 billion.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2022

Upgrades

Benzinga

Here's How Much You Would Have Made Owning American Tower Stock In The Last 15 Years

American Tower (NYSE:AMT) has outperformed the market over the past 15 years by 6.15% on an annualized basis producing an average annual return of 12.93%. Currently, American Tower has a market capitalization of $123.95 billion.

Benzinga

Analyst Ratings for American Tower

Analysts have provided the following ratings for American Tower (NYSE:AMT) within the last quarter:

Benzinga

Here's How Much You Would Have Made Owning American Tower Stock In The Last 20 Years

American Tower (NYSE:AMT) has outperformed the market over the past 20 years by 16.27% on an annualized basis producing an average annual return of 23.36%. Currently, American Tower has a market capitalization of $118.49 billion.

Benzinga

How Is The Market Feeling About American Tower?

American Tower's (NYSE:AMT) short percent of float has risen 48.68% since its last report. The company recently reported that it has 5.14 million shares sold short, which is 1.13% of all regular shares that are available for trading.

Benzinga

Here's How Much You Would Have Made Owning American Tower Stock In The Last 10 Years

American Tower (NYSE:AMT) has outperformed the market over the past 10 years by 1.83% on an annualized basis producing an average annual return of 13.46%. Currently, American Tower has a market capitalization of $109.29 billion.

Benzinga

Looking Into American Tower's Recent Short Interest

American Tower's (NYSE:AMT) short percent of float has fallen 6.17% since its last report. The company recently reported that it has 3.46 million shares sold short, which is 0.76% of all regular shares that are available for trading.

1 2 3

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.